Related references
Note: Only part of the references are listed.Drug-induced cholestasis assay in primary hepatocytes
Pieter Van Brantegem et al.
METHODSX (2020)
Effect of Cryopreservation on Enzyme and Transporter Activities in Suspended and Sandwich Cultured Rat Hepatocytes
Janneke Keemink et al.
AAPS JOURNAL (2018)
Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures
Robim M. Rodrigues et al.
ARCHIVES OF TOXICOLOGY (2018)
A Study on Pharmacokinetics of Bosentan with Systems Modeling, Part 1: Translating Systemic Plasma Concentration to Liver Exposure in Healthy Subjects
Rui Li et al.
DRUG METABOLISM AND DISPOSITION (2018)
Species differences in bile acids II. Bile acid metabolism
Rhishikesh Thakare et al.
JOURNAL OF APPLIED TOXICOLOGY (2018)
Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent
Celine Parmentier et al.
TOXICOLOGY LETTERS (2018)
Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury
Eiichiro Ogimura et al.
TOXICOLOGICAL SCIENCES (2017)
A bosentan pharmacokinetic study to investigate dosing regimens in paediatric patients with pulmonary arterial hypertension: FUTURE-3
Rolf M. F. Berger et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Pharmacokinetics of drugs for pediatric pulmonary hypertension
Kouichi Nakau et al.
PEDIATRICS INTERNATIONAL (2016)
Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes
Marlies Oorts et al.
TOXICOLOGY IN VITRO (2016)
Prediction of Altered Bile Acid Disposition Due to Inhibition of Multiple Transporters: An Integrated Approach Using Sandwich-Cultured Hepatocytes, Mechanistic Modeling, and Simulation
Cen Guo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
A versatile pipeline for the multi-scale digital reconstruction and quantitative analysis of 3D tissue architecture
Hernan Morales-Navarrete et al.
ELIFE (2015)
Species Differences in Hepatobiliary Disposition of Taurocholic Acid in Human and Rat Sandwich-Cultured Hepatocytes: Implications for Drug-Induced Liver Injury
Kyunghee Yang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Chimeric TK-NOG Mice: A Predictive Model for Cholestatic Human Liver Toxicity
Dan Xu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Evaluation of the Endothelin Receptor Antagonists Ambrisentan, Bosentan, Macitentan, and Sitaxsentan as Hepatobiliary Transporter Inhibitors and Substrates in Sandwich-Cultured Human Hepatocytes
Eve-Irene Lepist et al.
PLOS ONE (2014)
Hepatocyte-based in vitro model for assessment of drug-induced cholestasis
Sagnik Chatterjee et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Toxicity and intracellular accumulation of bile acids in sandwich-cultured rat hepatocytes: Role of glycine conjugates
Sagnik Chatterjee et al.
TOXICOLOGY IN VITRO (2014)
Association of CYP2C9*2 With Bosentan-Induced Liver Injury
S. M. Markova et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity
Tom De Bruyn et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
A Multifactorial Approach to Hepatobiliary Transporter Assessment Enables Improved Therapeutic Compound Development
Ryan E. Morgan et al.
TOXICOLOGICAL SCIENCES (2013)
Hepatic Basolateral Efflux Contributes Significantly to Rosuvastatin Disposition I: Characterization of Basolateral Versus Biliary Clearance Using a Novel Protocol in Sandwich-Cultured Hepatocytes
Nathan D. Pfeifer et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Endogenous bile acid disposition in rat and human sandwich-cultured hepatocytes
Tracy L. Marion et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
In Vitro Inhibition of the Bile Salt Export Pump Correlates with Risk of Cholestatic Drug-Induced Liver Injury in Humans
Sarah Dawson et al.
DRUG METABOLISM AND DISPOSITION (2012)
Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes
J. Craig Hartman et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)
Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity
Brandon Swift et al.
DRUG METABOLISM REVIEWS (2010)
High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma
Xiaoqiang Xiang et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Interference with Bile Salt Export Pump Function Is a Susceptibility Factor for Human Liver Injury in Drug Development
Ryan E. Morgan et al.
TOXICOLOGICAL SCIENCES (2010)
Rapid quantification of bile acids and their conjugates in serum by liquid chromatography-tandem mass spectrometry
Max Scherer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs
Par Matsson et al.
PHARMACEUTICAL RESEARCH (2009)
Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease
Carsten Gnewuch et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Bosentan is a substrate of human OATP1B1 and OATP1B3:: Inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin a, rifampicin, and sildenafil
Alexander Treiber et al.
DRUG METABOLISM AND DISPOSITION (2007)
Results of European post-marketing surveillance of bosentan in pulmonary hypertension
M. Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1) by bosentan:: A mechanism for species differences in hepatotoxicity
Elaine M. Leslie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2
Yuji Mano et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2007)
Upregulation of a basolateral FXR-dependent bile acid efflux transporter OST alpha-OST beta in cholestasis in humans and rodents
James L. Boyer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Human hepatic mitochondria generate reactive oxygen species and undergo the permeability transition in response to hydrophobic bile acids
TJ Sokol et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2005)
Xenobiotics inhibit hepatic uptake and biliary excretion of taurocholate in rat hepatocytes
DC Kemp et al.
TOXICOLOGICAL SCIENCES (2005)
Impact of dimethyl sulfoxide on expression of nuclear receptors and drug-inducible cytochromes P450 in primary rat hepatocytes
T Su et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Drug therapy: Treatment of pulmonary arterial hypertension
M Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Clinical pharmacology of bosentan, a dual endothelin receptor antagonist
J Dingemanse et al.
CLINICAL PHARMACOKINETICS (2004)
Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS
BK Matuszewski et al.
ANALYTICAL CHEMISTRY (2003)
Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan
L Fouassier et al.
JOURNAL OF HEPATOLOGY (2002)
Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods
AM Almeida et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver
CJ Soroka et al.
HEPATOLOGY (2001)
The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions
K Fattinger et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition
B Yerushalmi et al.
HEPATOLOGY (2001)
Share Paper
